|Articles|May 1, 2001

May 2001
Volume 7
Issue 5

Total Cost Comparison of 2 Biopsy Methods for Nonpalpable Breast Lesions

Author(s)Balazs I. Bodai, MD, Beth Boyd, RN, Lurlene Brown, MD

Download PDF: Total Cost Comparison of 2 Biopsy Methods for Nonpalpable Breast Lesions

Articles in this issue

over 24 years ago

Article

Patient's Knowledge of Health Plan Coverage and Satisfaction with Care

over 24 years ago

Article

Development and Validation of the Pharmaceutical Care Satisfaction Questionnaire

over 24 years ago

Article

Health Insurance, Primary Care, and Preventable Hospitalization of Children in a Large State

over 24 years ago

Article

Impact of HMO Ownership on Management Processes and Utilization Outcomes

over 24 years ago

Article

Diabetes Mellitus in Managed Care: Complications and Resource Utilization

over 24 years ago

Article

Impact of Managed MediCal on California Family Practice Programs

over 24 years ago

Article

Treatment of Hypertension in a Managed Care Setting

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Total Cost Comparison of 2 Biopsy Methods for Nonpalpable Breast Lesions

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

New Dermatologic Therapies Make Waves at Maui Derm 2026